Implications of Mycoplasma and Ureaplasma infections on pregnant women

Implications of Mycoplasma and Ureaplasma infections on perinatal outcomes - Implications of Mycoplasma and Ureaplasma infections on perinatal outcomes

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054025

Enrollment

500

Registered

2024-04-01

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women who are managed in our hospital from 1st trimester to delivery.

Exclusion criteria

Exclusion criteria: Pregnant women transferred from another hospital from 2nd trimester Pregnant women interrupted maternal check-up due to transfer to another hospital Pregnant women without any maternal check-up

Design outcomes

Primary

Measure	Time frame
The prevalence of Mycoplasma, Ureaplasma infections Perinatal outcomes	—

Countries

Japan

Contacts

Public ContactMasanori Sumi

Rinku General Medical Center Obstetrics and gynecology

k-ogita@rgmc.izumisano.osaka.jp072-469-3111

Outcome results